Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Turcot syndrome × toripalimab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 20 Carcinoma, Hepatocellular 19 Stomach Neoplasms 13 Colorectal Neoplasms 12 Liver Neoplasms 6 Esophageal Neoplasms 5 Rectal Neoplasms 4 Pancreatic Neoplasms 4 Locally Advanced Rectal Cancer 3 Cholangiocarcinoma 3 Advanced Pancreatic Cancer 3 Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Microsatellite Stable Metastatic Colorectal Cancer 2 Klatskin Tumor 2 Gallbladder Neoplasms 2 Early Low Rectal Cancer 2 Colonic Neoplasms 2 Biliary Tract Neoplasms 2 Adenocarcinoma of the Stomach 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Carcinoma of Esophagus 1 Sarcoma 1 Radiotherapy 1 Pathologic Complete Response 1 Pancreatic Cancer Metastatic 1 PD-1 Antibody 1

Interventions

pembrolizumab 5 Nivolumab 5 Ipilimumab 4 avelumab 3 Neoadjuvant Therapy 3 durvalumab 2 atezolizumab 2 Specimen Handling 2 Immune Checkpoint Inhibitors 2 toripalimab 1 tislelizumab 1 spartalizumab 1 sintilimab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 danvatirsen 1 Taxes 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Oxaliplatin 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Irinotecan 1 Interleukin-2 1 Immunoglobulin G 1 IMM-101 1 Fluorouracil 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03926338 2025-11-20

PICC

Sun Yat-sen University

Phase 2 Recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡